BioSpace News Archive

Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that the Company has entered into a strategic collaboration (the “Collaboration”) with a Humboldt County-based cannabis processing company (the “Processor”) located in Arcata, California

Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, today announced the appointment of Peter Van Vlasselaer, Ph.D., to its Board of Directors.

IQVIA™ (NYSE:IQV) today announced that Novo Nordisk, a global healthcare company with nearly a century of innovation and leadership in diabetes care, has selected IQVIA’s market-leading Orchestrated Customer Engagement platform for deployment across Novo Nordisk International Operations.

Digicom Electronics, Inc., a technology and quality driven electronics manufacturing services company, announces that it has upgraded its Medical Quality Device Certification to ISO 13485:2016

Broe Real Estate Group (BREG), a private real estate investment firm headquartered in Denver, CO, confirmed the sale of a 121,789 square foot medical pavilion located at 9601 Blackwell Road in Rockville, MD.

Eisai announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (marketed as HALAVEN®) will be presented during the 41st San Antonio Breast Cancer Symposium (SABCS). The symposium will be held from December 4-8, 2018, in San Antonio, Texas.

Insurer offers educational program to close knowledge gap and encourage addiction prevention, treatment and recovery, in an effort to help curb the opioid crisis

Award-winning hazardous drug compounding system, Equashield Pro, will demo at American Society of Health System Pharmacy (ASHP) Midyear Meeting in Anaheim, CA

Feldan Therapeutics (hereafter “Feldan”), a preclinical biotechnology company specialized in the intracellular delivery of therapeutic proteins and peptides, has announced an investment of $1.3 million by Asahi Kasei Corporate Venture Capital (hereafter “AKCVC”).

Financial terms of the transaction are not being disclosed.